OPKO Health, Inc. (NASDAQ: OPK) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $1.2B. The Maz Rating grades it against the other companies in its sector.
OPKO Health, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.62, OPKO Health, Inc. trades at 2.4x sales and 1.1x book value. Over the last twelve months it generated about $500M of revenue and a net loss of $143M. It runs a gross margin of 38.6%, an operating margin of -25.5% and a net margin of -29.5%. It shows return on equity of -12.4%, return on invested capital of -5.8% and a free cash flow yield of -11.3%. On the balance sheet: a debt-to-equity ratio of 0.46 and a current ratio of 4.97. Over the past 52 weeks the share price ranged from $0.98 to $1.86, with a beta of 1.53.
OPKO Health, Inc. does not currently pay a dividend.
13 Wall Street analyst ratings cover the stock: 9 Buy, 3 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.